tiprankstipranks
Trending News
More News >
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
US Market

Pharma Bio Services (PBSV) Income Statement

Compare
45 Followers

Pharma Bio Services Income Statement

Last quarter (Q3 2025), Pharma Bio Services's total revenue was $1.96B, an increase of 81080.76% from the same quarter last year. In Q3, Pharma Bio Services's net income was $-204.25K. See Pharma Bio Services’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.51M$ 16.98M$ 19.40M$ 20.12M$ 21.56M
Gross Profit
$ 2.52M$ 5.07M$ 4.88M$ 5.36M$ 6.67M
Operating Expenses
$ 3.80M$ 3.95M$ 3.71M$ 9.21M$ 4.44M
Depreciation and Amortization
$ 181.16K$ 194.32K$ 51.11K$ 72.73K$ 86.28K
EBITDA
$ -1.11M$ 1.31M$ 1.23M$ -3.78M$ 2.38M
Operating Income
$ -1.29M$ 1.12M$ 1.17M$ -3.85M$ 2.23M
Other Income/Expenses
$ 532.14K$ 570.08K$ 13.42K$ 1.98M$ 64.46K
Pretax Income
$ -755.45K$ 1.69M$ 1.19M$ -1.88M$ 2.29M
Net Income
$ -777.62K$ 1.31M$ 1.01M$ -2.09M$ 2.05M
Per Share Metrics
Basic EPS
$ -0.03$ 0.06$ 0.04$ -0.09$ 0.09
Diluted EPS
$ -0.03$ 0.06$ 0.04$ -0.09$ 0.09
Weighted Average Shares Outstanding
22.97M 22.97M 23.00M 23.03M 23.00M
Weighted Average Shares Outstanding (Diluted)
22.97M 23.00M 23.03M 23.03M 23.04M
Currency in USD

Pharma Bio Services Earnings and Revenue History